(Q53582511)
Statements
Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors. (English)
Clarke SA
Hoskins NL
Jordan GR
Marsh DR
18 December 2006
40
4
939-947